Covid-19 Vaccine Trial
- All
- News
- Videos
-
New Cancer Vaccine Offers Hope: Early Trials Of mRNA Vaccine Show Encouraging Results
Modernas new cancer vaccine, mRNA-4359, shows promising results in early clinical trials. Utilizing mRNA technology, similar to its Covid-19 vaccine, this treatment primes the immune system to identify and destroy cancer cells.
-
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled"
An American woman who claims she was "permanently disabled" after taking part in the US clinical trial of AstraZeneca's COVID-19 vaccine is suing the drug maker because they failed to provide her with medical care for her side effects.
-
High Hopes For Nasal Covid Vaccines Despite "Disappointing" Trial
Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say.
-
AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.
-
Bharat Biotech Says Intranasal Covid Vaccine Found Safe In Booster Trials
Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
Covid Nasal Vaccine's Phase 3 Trials Completed, Says Bharat Biotech Chief
Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India next month.
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
Infant Covid Vaccine Succeeded In Trial, Says Moderna
US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children aged six months to six years after the two-shot regimen was found to be safe and produced a strong immune response.
-
US Health Regulator Clears Covaxin For Clinical Trials In Adults In America
Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).
-
India's 1st Homegrown mRNA Vaccine In Final Clinical Trial Stage: Centre
India's first homegrown mRNA COVID-19 vaccine is currently under final clinical trial stages, the government said on Thursday.
-
Indonesia Starts Testing Homegrown Covid Vaccine On Humans
Indonesia began testing a homegrown Covid-19 vaccine on humans Wednesday after getting the green light from the drug regulator as the country faces a rising wave of virus cases.
-
Pfizer-BioNTech Begin Trials For An Omicron-Specific Vaccine
Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday.
-
Fourth Covid Vaccine "Partially" Effective Against Omicron: Study
Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only "partially" effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.
-
AstraZeneca, Given As Booster, Gives Higher Antibodies Against Omicron
AstraZeneca said on Thursday preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta, Delta, Alpha and Gamma, when given as a th
-
New Cancer Vaccine Offers Hope: Early Trials Of mRNA Vaccine Show Encouraging Results
Modernas new cancer vaccine, mRNA-4359, shows promising results in early clinical trials. Utilizing mRNA technology, similar to its Covid-19 vaccine, this treatment primes the immune system to identify and destroy cancer cells.
-
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled"
An American woman who claims she was "permanently disabled" after taking part in the US clinical trial of AstraZeneca's COVID-19 vaccine is suing the drug maker because they failed to provide her with medical care for her side effects.
-
High Hopes For Nasal Covid Vaccines Despite "Disappointing" Trial
Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say.
-
AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.
-
Bharat Biotech Says Intranasal Covid Vaccine Found Safe In Booster Trials
Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
Covid Nasal Vaccine's Phase 3 Trials Completed, Says Bharat Biotech Chief
Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India next month.
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
Infant Covid Vaccine Succeeded In Trial, Says Moderna
US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children aged six months to six years after the two-shot regimen was found to be safe and produced a strong immune response.
-
US Health Regulator Clears Covaxin For Clinical Trials In Adults In America
Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).
-
India's 1st Homegrown mRNA Vaccine In Final Clinical Trial Stage: Centre
India's first homegrown mRNA COVID-19 vaccine is currently under final clinical trial stages, the government said on Thursday.
-
Indonesia Starts Testing Homegrown Covid Vaccine On Humans
Indonesia began testing a homegrown Covid-19 vaccine on humans Wednesday after getting the green light from the drug regulator as the country faces a rising wave of virus cases.
-
Pfizer-BioNTech Begin Trials For An Omicron-Specific Vaccine
Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday.
-
Fourth Covid Vaccine "Partially" Effective Against Omicron: Study
Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only "partially" effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.
-
AstraZeneca, Given As Booster, Gives Higher Antibodies Against Omicron
AstraZeneca said on Thursday preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta, Delta, Alpha and Gamma, when given as a th
